News & Perspective

Jul 11, 2012

Jul 11, 2012

Study flags drop in antivirals for hospitalized flu patients

(CIDRAP News) – Researchers following recent antiviral trends in the United States have found a troubling drop in the use of the drugs for treating hospitalized patients with lab-confirmed flu, especially children.

Jul 10, 2012

Jul 10, 2012

Studies examine safety of adjuvanted pandemic vaccine

(CIDRAP News) – As researchers continue to sort out safety issues surrounding the monovalent vaccine used during the 2009 H1N1 flu pandemic, two new reports focusing mainly on an adjuvanted version suggest that immunization was safe for babies born to vaccinated pregnant women and that it was linked to a small but significant risk of Guillain-Barre syndrome (GBS) in some patients.

Jul 06, 2012

Jul 06, 2012

FLU NEWS SCAN: Resistant H1N1, H5N1 in Indonesia

Antiviral-resistant H1N1 virus in Australia didn't spread farAn oseltamivir-resistant 2009 H1N1 virus that spread in one Australian community in 2011 apparently did not escape to a nearby large city, according to a report published in Eurosurveillance yesterday. Researchers previously reported the community spread of a resistant 2009 H1N1 virus in the Newcastle, Australia, area from June through August of 2011, the report notes.

Jun 27, 2012

Jun 27, 2012

CDC estimate of global H1N1 pandemic deaths: 284,000

(CIDRAP News) – Working with admittedly sparse data, a research team led by the US Centers for Disease Control and Prevention (CDC) has estimated the global death toll from the 2009 H1N1 influenza pandemic at more than 284,000, about 15 times the number of laboratory-confirmed cases.

Jun 26, 2012

Jun 26, 2012

HHS lists H1N1's lessons for honing pandemic readiness

(CIDRAP News) – During the 2009 influenza pandemic, clinicians were frustrated by the lack of useful diagnostic tests, the government had no national system for monitoring stress on healthcare facilities, and there was some duplication in federal media campaigns.

Jun 20, 2012

Jun 20, 2012

CSL says flu vaccine components led to kids' seizures

(CIDRAP News) – Australia's CSL Biotherapies said today that viral components of its Fluvax seasonal flu vaccine led to the unexpected rise in febrile seizures in young Australian children during the 2010 flu season.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»